|
|
|
|
| LEADER |
00000nam a2200000 a 4500 |
| 001 |
2336935 |
| 003 |
ICU |
| 005 |
20030520153600.0 |
| 008 |
950830s1995 onc b f000 0 eng d |
| 020 |
|
|
|a 0660159112
|
| 035 |
|
|
|a (ICU)BID21116683
|
| 035 |
|
|
|a (OCoLC)32712182
|
| 040 |
|
|
|a MUZ
|c MUZ
|d ICU
|d OrLoB-B
|d OCoLC
|
| 041 |
0 |
|
|a eng
|
| 086 |
|
|
|a Cat. H42-2/67-1995E
|
| 110 |
1 |
|
|a Canada.
|b Special Advisory Committee on Reproductive Physiology.
|0 http://id.loc.gov/authorities/names/n88044929
|1 http://viaf.org/viaf/149584195
|
| 245 |
1 |
0 |
|a Menopause :
|b a report /
|c by the Special Advisory Committee on Reproductive Physiology to the Drugs Directorate, Health Protection Branch, Health Canada.
|
| 260 |
|
|
|a [Ottawa] :
|b Health Canada,
|c 1995.
|
| 300 |
|
|
|a 99 p. ;
|c 28 cm.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|0 http://id.loc.gov/vocabulary/contentTypes/txt
|
| 337 |
|
|
|a unmediated
|b n
|2 rdamedia
|0 http://id.loc.gov/vocabulary/mediaTypes/n
|
| 338 |
|
|
|a volume
|b nc
|2 rdacarrier
|0 http://id.loc.gov/vocabulary/carriers/nc
|
| 504 |
|
|
|a Includes bibliographical references.
|
| 505 |
0 |
0 |
|g 1.
|t Introduction --
|g 2.
|t Endocrinology of Menopause --
|g 3.
|t The Postmenopausal Ovary and Steroid Metabolism --
|g 4.
|t Physiologic Changes of Menopause --
|g 5.
|t Management of the Patient --
|g 6.
|t Risks of Hormone Replacement Therapy --
|g 7.
|t Guidelines for Hormone Replacement Therapy --
|g 8.
|t Conclusion --
|g 9.
|t Labelling.
|
| 650 |
|
2 |
|a Menopause
|x physiology.
|
| 650 |
|
2 |
|a Menopause
|x drug effects.
|
| 650 |
|
2 |
|a Estrogen Replacement Therapy.
|
| 650 |
|
2 |
|a Climacteric.
|
| 650 |
|
0 |
|a Menopause.
|0 http://id.loc.gov/authorities/subjects/sh85083590
|
| 650 |
|
7 |
|a Menopause
|x Complications.
|2 fast
|0 http://id.worldcat.org/fast/fst01016247
|
| 650 |
|
7 |
|a Menopause
|x Hormone therapy.
|2 fast
|0 http://id.worldcat.org/fast/fst01016254
|
| 650 |
|
7 |
|a Menopause
|x Physiological aspects.
|2 fast
|0 http://id.worldcat.org/fast/fst01016258
|
| 710 |
1 |
|
|a Canada.
|b Drugs Directorate.
|0 http://id.loc.gov/authorities/names/n81067736
|1 http://viaf.org/viaf/134783487
|
| 901 |
|
|
|a ToCBNA
|
| 903 |
|
|
|a HeVa
|
| 903 |
|
|
|a Hathi
|
| 929 |
|
|
|a cat
|
| 999 |
f |
f |
|i 0cffeff4-2a19-5a5d-ae6d-caf9be3032a4
|s cfcd704b-8f76-575c-a5b2-bc778b5695c6
|
| 928 |
|
|
|t Library of Congress classification
|a RG186.C362 1995
|l ASR
|c ASR-SciASR
|i 3096971
|
| 927 |
|
|
|t Library of Congress classification
|a RG186.C362 1995
|l ASR
|c ASR-SciASR
|e CRERAR
|b 41530976
|i 3991512
|
